Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.

[1]  A. M. Lefer,et al.  Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids. , 1984, Canadian journal of physiology and pharmacology.

[2]  A. M. Lefer,et al.  Thromboxane A2 in acute myocardial infarction. , 1984, American heart journal.

[3]  F. H. Schmidt,et al.  The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug. , 1984, Thrombosis research.

[4]  J. Vermylen,et al.  BM 13.177, A SELECTIVE BLOCKER OF PLATELET AND VESSEL WALL THROMBOXANE RECEPTORS, IS ACTIVE IN MAN , 1984, The Lancet.

[5]  A. M. Lefer,et al.  Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia. , 1983, Archives internationales de pharmacodynamie et de therapie.

[6]  A. M. Lefer,et al.  Protection of Ischemic Cat Myocardium By CGS‐13080, a Selective Potent Thromboxane A2 Synthesis Inhibitor , 1983, Journal of cardiovascular pharmacology.

[7]  G. L. Le Breton,et al.  Specific binding of the thromboxane A2 antagonist 13-azaprostanoic acid to human platelet membranes. , 1983, Biochimica et biophysica acta.

[8]  A. M. Lefer,et al.  Role of Prostacyclin in the Preservation of Ischemic Myocardial Tissue in the Perfused Cat Heart , 1980, Circulation research.

[9]  W. J. Weidner,et al.  Influence of indomethacin on cation excretion after acute unilateral nephrectomy in dogs. , 1980, Prostaglandins and medicine.

[10]  L. Becker,et al.  Salvage of ischemic myocardium by ibuprofen during infarction in the conscious dog. , 1980, The American journal of cardiology.

[11]  A. M. Lefer,et al.  Thromboxane Release During Pacing-induced Angina Pectoris: Possible Vasoconstrictor Influence on the Coronary Vasculature , 1980, Circulation.

[12]  E. F. Smith,et al.  Influence of thromboxane inhibition on the severity of myocardial ischemia in cats. , 1980, Canadian journal of physiology and pharmacology.

[13]  P. Walinsky,et al.  Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's angina. , 1979, Prostaglandins and medicine.

[14]  A. M. Lefer,et al.  Actions of prostaglandins on isolated perfused cat coronary arteries. , 1978, The American journal of physiology.

[15]  P. Needleman,et al.  Cardiac and coronary prostaglandin synthesis and function. , 1978, The New England journal of medicine.

[16]  J. Oates,et al.  Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. , 1976, Science.

[17]  A. M. Lefer,et al.  Arachidonic acid in splanchnic artery occlusion shock. , 1976, The American journal of physiology.

[18]  A. M. Lefer,et al.  Influence of nonsteroidal anti-inflammatory agents on myocardial ischemia in the cat. , 1976, The Journal of pharmacology and experimental therapeutics.

[19]  M. Hamberg,et al.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Rosalki.  An improved procedure for serum creatine phosphokinase determination. , 1967, The Journal of laboratory and clinical medicine.

[21]  H. Patscheke,et al.  Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. , 1984, Biomedica biochimica acta.

[22]  R. A. Coleman,et al.  Studies on the characterization of prostanoid receptors. , 1983, Advances in prostaglandin, thromboxane, and leukotriene research.

[23]  A. M. Lefer,et al.  Preservation of ischemic myocardium by pinane thromboxane A2. , 1980, The American journal of physiology.

[24]  S. Morooka,et al.  Heart Attack Induced Experimentally with Thromboxane A2 , 1977 .